These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 31220350)

  • 1. Considering the Links Between Nonalcoholic Fatty Liver Disease and Insulin Resistance: Revisiting the Role of Protein Kinase C ε.
    Samuel VT; Petersen MC; Gassaway BM; Vatner DF; Rinehart J; Shulman GI
    Hepatology; 2019 Dec; 70(6):2217-2220. PubMed ID: 31220350
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans.
    Ter Horst KW; Gilijamse PW; Versteeg RI; Ackermans MT; Nederveen AJ; la Fleur SE; Romijn JA; Nieuwdorp M; Zhang D; Samuel VT; Vatner DF; Petersen KF; Shulman GI; Serlie MJ
    Cell Rep; 2017 Jun; 19(10):1997-2004. PubMed ID: 28591572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance.
    Petersen MC; Madiraju AK; Gassaway BM; Marcel M; Nasiri AR; Butrico G; Marcucci MJ; Zhang D; Abulizi A; Zhang XM; Philbrick W; Hubbard SR; Jurczak MJ; Samuel VT; Rinehart J; Shulman GI
    J Clin Invest; 2016 Nov; 126(11):4361-4371. PubMed ID: 27760050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein Kinase C Epsilon Deletion in Adipose Tissue, but Not in Liver, Improves Glucose Tolerance.
    Brandon AE; Liao BM; Diakanastasis B; Parker BL; Raddatz K; McManus SA; O'Reilly L; Kimber E; van der Kraan AG; Hancock D; Henstridge DC; Meikle PJ; Cooney GJ; James DE; Reibe S; Febbraio MA; Biden TJ; Schmitz-Peiffer C
    Cell Metab; 2019 Jan; 29(1):183-191.e7. PubMed ID: 30318338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study.
    Erkan G; Sayın I; Polat FB; Çorakçı A; Ataç GK; Değertekin H
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():63-8. PubMed ID: 25910371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition C-C chemokine receptor 2.
    Kim HM; Kim YM; Huh JH; Lee ES; Kwon MH; Lee BR; Ko HJ; Chung CH
    PLoS One; 2017; 12(6):e0179204. PubMed ID: 28598982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of glycosylphosphatidylinositol-specific phospholipase D on hepatic diacylglycerol accumulation, steatosis, and insulin resistance in diet-induced obesity.
    Masuda S; Fujishima Y; Maeda N; Tsugawa-Shimizu Y; Nakamura Y; Tanaka Y; Obata Y; Fukuda S; Nagao H; Kita S; Nishizawa H; Shimomura I
    Am J Physiol Endocrinol Metab; 2019 Feb; 316(2):E239-E250. PubMed ID: 30457913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
    Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
    Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance.
    Kwak MS; Kim D; Chung GE; Kim W; Kim YJ; Yoon JH
    Liver Int; 2015 Mar; 35(3):944-52. PubMed ID: 24684289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of Autophagy and Protein Kinase C-epsilon in Lipid Metabolism of Nonalcoholic Fatty Liver Cell Models.
    Yan R; Niu CY; Tian Y
    Arch Med Res; 2018 Aug; 49(6):381-390. PubMed ID: 30573200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of nonalcoholic steatohepatitis and significant fibrosis in non-obese nonalcoholic fatty liver disease.
    Kim D; Kim W; Joo SK; Kim JH; Harrison SA; Younossi ZM; Ahmed A
    Liver Int; 2019 Feb; 39(2):332-341. PubMed ID: 30298568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of the renin-angiotensin system blockers on nonalcoholic fatty liver disease and insulin resistance in C57BL/6 mice.
    Frantz ED; Penna-de-Carvalho A; Batista Tde M; Aguila MB; Mandarim-de-Lacerda CA
    Metab Syndr Relat Disord; 2014 May; 12(4):191-201. PubMed ID: 24517411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
    Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
    World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone Elicits an Adiponectin-Mediated Insulin-Sensitizing Action at the Adipose Tissue-Liver Axis in Otsuka Long-Evans Tokushima Fatty Rats.
    Li J; Xue YM; Zhu B; Pan YH; Zhang Y; Wang C; Li Y
    J Diabetes Res; 2018; 2018():4627842. PubMed ID: 30225267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term dietary supplementation with low-dose nobiletin ameliorates hepatic steatosis, insulin resistance, and inflammation without altering fat mass in diet-induced obesity.
    Kim YJ; Choi MS; Woo JT; Jeong MJ; Kim SR; Jung UJ
    Mol Nutr Food Res; 2017 Aug; 61(8):. PubMed ID: 28116779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An AGTR1 Variant Worsens Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome.
    de Gracia Hahn D; Duret A; Mann JP
    Am J Gastroenterol; 2019 Apr; 114(4):556-559. PubMed ID: 30951517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of JNK suppresses autophagy and attenuates insulin resistance in a rat model of nonalcoholic fatty liver disease.
    Yan H; Gao Y; Zhang Y
    Mol Med Rep; 2017 Jan; 15(1):180-186. PubMed ID: 27909723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The expression of chemerin and the influence of sitagliptin on its expression in non-alcoholic fatty liver disease rats complicated with prediabetes].
    Zhang L; Gao XF; Wang YH
    Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(30):2407-2413. PubMed ID: 30138985
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term fatty liver-induced insulin resistance in orotic acid-induced nonalcoholic fatty liver rats.
    Han X; Liu C; Xue Y; Wang J; Xue C; Yanagita T; Gao X; Wang Y
    Biosci Biotechnol Biochem; 2016; 80(4):735-43. PubMed ID: 26775542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
    Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K
    J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.